Grantham, Mayo, Van Otterloo & Co (GMO)’s Freeport-McMoran FCX Stock Holding History
Bought
Maintained
Sold
Other funds holding FCX
Grantham, Mayo, Van Otterloo & Co (GMO)'s FCX Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Freeport-McMoran (FCX) stake by 26% in Q2 2026, selling an estimated $11.5M and leaving 521,581 shares worth $32.8M. The position accounts for 0.07% of the portfolio, ranked #123.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in FCX in Q2 2013 and has held it in 51 quarters since. The position peaked at $84.9M in Q1 2024. 1,892 funds tracked by Wall St. Rank hold FCX as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 521,581 shares of Freeport-McMoran worth $32.8M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 179,544 Freeport-McMoran shares in Q2 2026, an estimated $11.5M.
- Freeport-McMoran made up 0.07% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #123 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Freeport-McMoran in Q2 2013 and has held it in 51 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Freeport-McMoran position peaked at $84.9M in Q1 2024.
- 1,892 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.